Loading clinical trials...
Loading clinical trials...
Association Between Some Candidate Single Nucleotide Polymorphisms and Postherpetic Neuralgia
Postherpetic neuralgia (PHN) is a common condition and affecting 5 to 30% of the herpes zoster patients. In some cases, the pain remained refractory after first and second line treatment for herpes zoster. This suggests that there may be genetic variants that make some patients susceptible to PHN. Using saliva samples from herpes zoster patients the investigators are going to analyze the relationship between single nucleotide polymorphisms (SNPs) in genes that are known to be involved in pain and PHN.
Age
50 - No limit years
Sex
ALL
Healthy Volunteers
No
The second affiliated hospital of Zhejiang University
Hangzhou, Zhejiang, China
Start Date
April 1, 2018
Primary Completion Date
February 13, 2019
Completion Date
February 13, 2019
Last Updated
April 23, 2019
181
ACTUAL participants
Lead Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
NCT07000409
NCT06896994
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06232486